STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
36 hedge funds and large institutions have $87.7M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.9M | |
| 2 | +$995K | |
| 3 | +$769K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$191K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$91.4K |
Top Sellers
| 1 | -$3.39M | |
| 2 | -$1.64M | |
| 3 | -$309K | |
| 4 |
Two Sigma Investments
New York
|
-$182K |
| 5 |
Morgan Stanley
New York
|
-$161K |